omega-n-methylarginine has been researched along with 4-aminopyridine in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (4-aminopyridine) | Trials (4-aminopyridine) | Recent Studies (post-2010) (4-aminopyridine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 4,141 | 134 | 804 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grbović, L; Jovanović, A; Jovanović, S; Tulić, I | 1 |
1 other study(ies) available for omega-n-methylarginine and 4-aminopyridine
| Article | Year |
|---|---|
Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery.
Topics: 4-Aminopyridine; Adult; Arteries; Cyclooxygenase Inhibitors; Diethylcarbamazine; Endothelium, Vascular; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; In Vitro Techniques; Indomethacin; Lipoxygenase Inhibitors; Methylene Blue; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Potassium Channel Blockers; Receptors, Vasoactive Intestinal Peptide; Uterus; Vasoactive Intestinal Peptide; Vasodilation | 1998 |